Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
Clinical trial NCT02847650 · TERMINATED
Trial details
- NCT number
- NCT02847650
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2018-01-29
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.